Literature DB >> 2298825

Drug-induced alterations of tumor necrosis factor-mediated cytotoxicity: discrimination of early versus late stage action.

F C Kull1, J M Besterman.   

Abstract

The killing of L-M cells by murine tumor necrosis factor (mTNF) was investigated by a combination of drug, antiserum neutralization, and kinetic studies. Kinetic studies with 125I-mTNF showed that the bulk of association of ligand with L-M cells peaked within 2 hr and the ligand was not degraded. Cell surface receptors were depleted (down regulated) by 6 hr when death commenced. The off-rates of acid-dissociable (surface bound) and acid-indissociable (internalized) compartments were found to be 9 min and 35 hr, respectively. Nevertheless, complete cell killing required the persistent presence of mTNF for up to 20 hr. This requirement was ablated by the concomitant addition of cycloheximide. Antiserum completely inhibited cytotoxicity when it was applied up to 4 hr after mTNF, but antiserum added 1 hr after mTNF was not neutralizing in the presence of cycloheximide. Thus, the inclusion of cycloheximide temporally dissociated early events (internalization and signal transduction) from lysis. Other drugs with and without cycloheximide were found to preferentially affect either early or later aspects of cell death. Phorbol myristate acetate and the ionophore A23187 were potent inhibitors of cytotoxicity, and staurosporine was a potent enhancer. These agents were more effective when added 1 hr before mTNF and cycloheximide than when added 1 hr after and likely affected early events in the cytolytic program. In contrast, chloroquine and cAMP likely affect more terminal aspects of cytotoxicity. Dibutyrylcyclic AMP, cholera, and pertussis toxins enhanced cytotoxicity. They were equipotent when added either before or after mTNF regardless of the presence of cycloheximide. Likewise, chloroquine was an equipotent inhibitor when added either before or after mTNF regardless of the presence of cycloheximide. Agents that primarily affect association events may be more likely to impinge on other TNF-mediated activities than agents that primarily affect lysis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2298825     DOI: 10.1002/jcb.240420102

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  Bone marrow transplantation reproduces the tristetraprolin-deficiency syndrome in recombination activating gene-2 (-/-) mice. Evidence that monocyte/macrophage progenitors may be responsible for TNFalpha overproduction.

Authors:  E Carballo; G S Gilkeson; P J Blackshear
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Resistance to tumor necrosis factor-induced cell death mediated by PMCA4 deficiency.

Authors:  K Ono; X Wang; J Han
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

3.  Falciparum malaria and hypoglycaemia.

Authors:  M Odeh
Journal:  Postgrad Med J       Date:  1993-04       Impact factor: 2.401

4.  Structural changes of tumor necrosis factor alpha associated with membrane insertion and channel formation.

Authors:  R L Baldwin; M L Stolowitz; L Hood; B J Wisnieski
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

Review 5.  Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.

Authors:  K D Rainsford; Ann L Parke; Matthew Clifford-Rashotte; W F Kean
Journal:  Inflammopharmacology       Date:  2015-08-06       Impact factor: 5.093

6.  Hypoxia/reoxygenation-mediated induction of astrocyte interleukin 6: a paracrine mechanism potentially enhancing neuron survival.

Authors:  Y Maeda; M Matsumoto; O Hori; K Kuwabara; S Ogawa; S D Yan; T Ohtsuki; T Kinoshita; T Kamada; D M Stern
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.